Cargando…

Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone

OBJECTIVES: A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Müllerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotierzo, Manuela, Urbain, Victor, Dupuy, Anne-Marie, Cristol, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145750/
https://www.ncbi.nlm.nih.gov/pubmed/34095410
http://dx.doi.org/10.1016/j.plabm.2021.e00220
_version_ 1783697246475255808
author Lotierzo, Manuela
Urbain, Victor
Dupuy, Anne-Marie
Cristol, Jean-Paul
author_facet Lotierzo, Manuela
Urbain, Victor
Dupuy, Anne-Marie
Cristol, Jean-Paul
author_sort Lotierzo, Manuela
collection PubMed
description OBJECTIVES: A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Müllerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of ovarian reserve, in diagnosis of granulosa cells cancer and in the investigation of gonadal disorders. We compared Lumipulse G AMH assay performances with other methods largely applied for AMH measurements. DESIGN AND METHODS: The Lumipulse G AMH method based on two-step sandwich chemiluminescence enzyme immunoassay was assessed on Lumipulse G600II analyzer. The evaluation study included imprecisions, sensitivity and linearity whereas a comparison study was performed on a heterogeneous population of 114 patients by using the Elecsys AMH Plus assay on COBAS 8000 e602 module (Roche Diagnostics). RESULTS: Lumipulse G AMH system showed good repeatability (within-run imprecision) with CV values below 1% (0.5% and 0.9% for high and low serum pools). Similarly within-laboratory imprecision was assessed with CV values of 2.5% and 1.6% for high and low level controls respectively. A linearity regression formula of 1.0119x-0.067 with a coefficient of determination (r(2)) equal to 0.999 was obtained in a range from 0.044 to 22.42 ​ng/ml. Passing-Bablok regression analysis was performed for assay comparability of AMH measurements. Results were closely correlated (correlation coefficient ​= ​0.997) with a regression equation (y ​= ​1.230x-0.025) showing a positive slope. Also, Bland-Altman analysis confirmed a good agreement between Lumipulse G AMH and Roche Elecsys AMH Plus assays with a bias of 17.76% in a large measurement range. CONCLUSIONS: The performance of Lumipulse G AMH system was highly comparable with that of Roche Elecsys AMH Plus assay although approximately 10% higher values of AMH levels were observed for Lumipulse AMH system at all range of concentrations. Nevertheless the Lumipulse G system seems to be largely suitable for quantitative determination of AMH level in small-scale laboratory because of the reduced size and the use of single cartridge per test assuring flexibility and easy handling.
format Online
Article
Text
id pubmed-8145750
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81457502021-06-03 Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone Lotierzo, Manuela Urbain, Victor Dupuy, Anne-Marie Cristol, Jean-Paul Pract Lab Med Full Length Article OBJECTIVES: A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Müllerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of ovarian reserve, in diagnosis of granulosa cells cancer and in the investigation of gonadal disorders. We compared Lumipulse G AMH assay performances with other methods largely applied for AMH measurements. DESIGN AND METHODS: The Lumipulse G AMH method based on two-step sandwich chemiluminescence enzyme immunoassay was assessed on Lumipulse G600II analyzer. The evaluation study included imprecisions, sensitivity and linearity whereas a comparison study was performed on a heterogeneous population of 114 patients by using the Elecsys AMH Plus assay on COBAS 8000 e602 module (Roche Diagnostics). RESULTS: Lumipulse G AMH system showed good repeatability (within-run imprecision) with CV values below 1% (0.5% and 0.9% for high and low serum pools). Similarly within-laboratory imprecision was assessed with CV values of 2.5% and 1.6% for high and low level controls respectively. A linearity regression formula of 1.0119x-0.067 with a coefficient of determination (r(2)) equal to 0.999 was obtained in a range from 0.044 to 22.42 ​ng/ml. Passing-Bablok regression analysis was performed for assay comparability of AMH measurements. Results were closely correlated (correlation coefficient ​= ​0.997) with a regression equation (y ​= ​1.230x-0.025) showing a positive slope. Also, Bland-Altman analysis confirmed a good agreement between Lumipulse G AMH and Roche Elecsys AMH Plus assays with a bias of 17.76% in a large measurement range. CONCLUSIONS: The performance of Lumipulse G AMH system was highly comparable with that of Roche Elecsys AMH Plus assay although approximately 10% higher values of AMH levels were observed for Lumipulse AMH system at all range of concentrations. Nevertheless the Lumipulse G system seems to be largely suitable for quantitative determination of AMH level in small-scale laboratory because of the reduced size and the use of single cartridge per test assuring flexibility and easy handling. Elsevier 2021-04-14 /pmc/articles/PMC8145750/ /pubmed/34095410 http://dx.doi.org/10.1016/j.plabm.2021.e00220 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Lotierzo, Manuela
Urbain, Victor
Dupuy, Anne-Marie
Cristol, Jean-Paul
Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title_full Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title_fullStr Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title_full_unstemmed Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title_short Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
title_sort evaluation of a new automated immunoassay for the quantification of anti-müllerian hormone
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145750/
https://www.ncbi.nlm.nih.gov/pubmed/34095410
http://dx.doi.org/10.1016/j.plabm.2021.e00220
work_keys_str_mv AT lotierzomanuela evaluationofanewautomatedimmunoassayforthequantificationofantimullerianhormone
AT urbainvictor evaluationofanewautomatedimmunoassayforthequantificationofantimullerianhormone
AT dupuyannemarie evaluationofanewautomatedimmunoassayforthequantificationofantimullerianhormone
AT cristoljeanpaul evaluationofanewautomatedimmunoassayforthequantificationofantimullerianhormone